Invest Securities reiterates its 'buy' recommendation and raises its target price on Assystem from 44 to 50 euros, following a clear outperformance of the stock in 2022 (+23 points), in the wake of the nuclear revival.

"While this paradigm shift will take time to materialize in results (from 2027/28) and is difficult to value, the group is benefiting in the meantime from resilient momentum", the analyst points out.

The research department also highlights two catalysts for 2023/24, with the disposal of stakes in Expleo and Framatome, which 'should enable us to complete our refocusing on nuclear power and put an end to the holding discount'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.